Inizio Group Limited
Inizio Group Limited, headquartered in Great Britain, is a leading player in the healthcare and life sciences industry. Founded in 2021, the company has rapidly established itself as a trusted partner for organisations seeking innovative solutions in clinical development, commercialisation, and market access. With a strong presence across Europe and North America, Inizio Group offers a diverse range of services, including strategic consulting, data analytics, and patient engagement. What sets Inizio Group apart is its commitment to delivering tailored solutions that enhance patient outcomes and drive business success. The company has achieved significant milestones, positioning itself as a go-to resource for pharmaceutical and biotechnology firms. With a focus on collaboration and excellence, Inizio Group Limited continues to shape the future of healthcare, making a meaningful impact in the industry.
DitchCarbon Score
How does Inizio Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inizio Group Limited's score of 78 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Inizio Group Limited's reported carbon emissions
Inizio Group Limited, headquartered in Great Britain, reported significant carbon emissions for the year 2024, totalling approximately 38,610,000 kg CO2e. This includes 3,861,000 kg CO2e from Scope 1 emissions, 1,940,000 kg CO2e from Scope 2 (market-based), and a substantial 35,476,000 kg CO2e from Scope 3 emissions. The previous year, 2023, saw total emissions of about 30,210,000 kg CO2e, with Scope 1 at 5,919,000 kg CO2e, Scope 2 at 1,945,000 kg CO2e (location-based), and Scope 3 at 30,210,000 kg CO2e. Inizio Group has set ambitious climate commitments, aiming for a 46.2% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2031, using a 2021 baseline. Additionally, they plan to reduce Scope 3 emissions from purchased goods and services, fuel- and energy-related activities, and business travel by 27.5% within the same timeframe. The company has committed to achieving net-zero emissions across all scopes by 2050, recognising the need for significant changes to meet these targets. In summary, Inizio Group Limited is actively working towards substantial emissions reductions and has established clear targets to align with global climate goals, demonstrating a commitment to sustainability in the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 8,008,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 2,846,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | 18,679,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inizio Group Limited is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
